• 1. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylmethanes

Introduction to (4-Methoxyphenyl)(phenyl)methanamine Hydrochloride (CAS No. 5267-46-9)

(4-Methoxyphenyl)(phenyl)methanamine Hydrochloride, chemically known as N-(4-methoxyphenyl)-benzylamine hydrochloride, is a significant compound in the field of pharmaceutical chemistry. With a CAS number of 5267-46-9, this compound has garnered attention due to its potential applications in drug development and medicinal research. The molecular structure of this compound features a benzylamine moiety attached to a 4-methoxyphenyl group, which contributes to its unique chemical properties and reactivity.

The synthesis of (4-Methoxyphenyl)(phenyl)methanamine Hydrochloride involves meticulous chemical processes that ensure high purity and yield. The hydrochloride salt form enhances the stability and solubility of the compound, making it more suitable for various pharmaceutical applications. This compound's versatility stems from its ability to participate in multiple chemical reactions, including nucleophilic substitutions and condensation reactions, which are pivotal in the synthesis of more complex molecules.

In recent years, (4-Methoxyphenyl)(phenyl)methanamine Hydrochloride has been explored for its pharmacological properties. Studies have indicated that this compound may exhibit significant biological activity, particularly in the realm of central nervous system (CNS) disorders. The presence of the 4-methoxyphenyl group suggests potential interactions with certain neurotransmitter receptors, which could be leveraged in the development of novel therapeutic agents. Furthermore, research has hinted at its potential role in modulating enzyme activities associated with neurodegenerative diseases.

One of the most compelling aspects of (4-Methoxyphenyl)(phenyl)methanamine Hydrochloride is its role as a building block in the synthesis of more complex pharmacophores. Pharmaceutical researchers have utilized this compound to develop novel derivatives with enhanced pharmacological profiles. For instance, modifications to the benzylamine moiety have led to compounds with improved binding affinities and selectivity for specific targets. These derivatives are being evaluated in preclinical studies to assess their efficacy and safety profiles.

The chemical properties of (4-Methoxyphenyl)(phenyl)methanamine Hydrochloride also make it a valuable intermediate in organic synthesis. Its ability to undergo various transformations allows chemists to construct intricate molecular architectures efficiently. This has opened up new avenues for the development of synthetic methodologies that are both efficient and environmentally friendly. The compound's stability under different reaction conditions further enhances its utility as a synthetic intermediate.

Recent advancements in computational chemistry have also contributed to a deeper understanding of (4-Methoxyphenyl)(phenyl)methanamine Hydrochloride's behavior. Molecular modeling studies have provided insights into its interactions with biological targets, helping researchers predict potential drug-like properties more accurately. These computational tools are particularly valuable in virtual screening campaigns, where large libraries of compounds are rapidly evaluated for their binding affinity and selectivity.

The pharmaceutical industry continues to invest heavily in research aimed at uncovering new therapeutic applications for (4-Methoxyphenyl)(phenyl)methanamine Hydrochloride. Ongoing clinical trials are assessing its efficacy in treating various conditions, including cognitive disorders and neuroinflammatory diseases. The results from these trials are expected to provide further validation for the compound's potential as a lead molecule in drug discovery.

Moreover, the environmental impact of synthesizing (4-Methoxyphenyl)(phenyl)methanamine Hydrochloride has been a focus of recent research. Efforts are underway to develop greener synthetic routes that minimize waste and reduce energy consumption. These initiatives align with broader trends in sustainable chemistry, where the goal is to develop processes that are both economically viable and environmentally responsible.

In conclusion, (4-Methoxyphenyl)(phenyl)methanamine Hydrochloride is a multifaceted compound with significant potential in pharmaceutical research and drug development. Its unique chemical properties, coupled with its role as a building block for more complex molecules, make it a valuable asset in medicinal chemistry. As research continues to uncover new applications and synthetic methodologies, this compound is poised to play an increasingly important role in the future of healthcare.

• 14692-29-6(Strontium acetate hemihydrate)
• 6298-96-0(1-(4-Methoxyphenyl)ethanamine)
• 62409-13-6(1-(3-Methoxyphenyl)ethanamine)
• 752924-21-3(3-Methoxybenzhydrylamine)
• 19293-62-0(4,4'-Dimethoxybenzhydrylamine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)